Simon Evers

Partner

Overview

Simon Evers is a partner in Crowell & Moring’s London office and a member of the Corporate Group. He advises international and domestic public companies, mid-sized and emerging businesses and investment firms on a wide range of M&A, equity financing, and other corporate matters.

Career & Education

    • University of Oxford, B.A., first class honors, Classics, 2003
    • Nottingham Law School, LPC, GDL, 2005
    • University of Oxford, B.A., first class honors, Classics, 2003
    • Nottingham Law School, LPC, GDL, 2005
    • Solicitor, England and Wales
    • Solicitor, England and Wales

Simon's Insights

Firm News | 2 min read | 05.22.26

Crowell & Moring Represents Kanders & Company in Acquisition of Ginkgo Bioworks’ Biosecurity Business

May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF)....

Representative Matters

  • PETRA on its public acquisition of HWSI Realisation Fund Limited.
  • Philantra on its acquisition of Argo Group’s Italian insurance business.
  • A.P. Moller–Maersk A/S on its disposal of Mercosul Line to CMA CGM; the establishment of its "2M" alliance with MSC Mediterranean Shipping Company; and its proposed "P3" alliance with MSC and CMA CGM.
  • Verisk Analytics on its £1.85 billion acquisition of Wood Mackenzie from Hellman & Friedman and others; and its acquisition of Healix Risk Rating.
  • Technip on its $13 billion merger with FMC Technologies.
  • TeliaSonera on the $1 billion sale of its holding in Nepalese telecom operator Ncell to Axiata.
  • GO Scale Capital investor consortium on its acquisition of an 80.1 percent interest in Lumileds from Philips.
  • Tele2 AB on the $3.55 billion sale of its Russian operations to VTB Group.
  • Delonex Energy on a $600 million investment by Warburg Pincus.
  • Premier Oil on its public acquisition of Encore Oil.
  • Bunzl on its sale of Bunzl Vending Services to Autobar UK.
  • Ineos on the acquisition from Tessenderlo of its chlor-vinyls business.
  • Unilever on the sale of Sanex to Colgate-Palmolive.
  • Centrica on the sell down of its investments in a number of U.K. wind farms.
  • The Winding-up Board of Glitnir Bank on its restructuring.
  • Numerous capital markets transactions, including the initial public offering of Fidelity China Situations and a placing and open offer of 3i Infrastructure.

Simon's Insights

Firm News | 2 min read | 05.22.26

Crowell & Moring Represents Kanders & Company in Acquisition of Ginkgo Bioworks’ Biosecurity Business

May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF)....

Simon's Insights

Firm News | 2 min read | 05.22.26

Crowell & Moring Represents Kanders & Company in Acquisition of Ginkgo Bioworks’ Biosecurity Business

May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF)....